| human | Q5 |
| P227 | GND ID | 1155331672 |
| P496 | ORCID iD | 0000-0002-9857-4728 |
| P214 | VIAF ID | 1997152261521717180007 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q96125224 | A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer |
| Q53293127 | A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. |
| Q34044755 | A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q34187283 | A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer |
| Q47978641 | A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer |
| Q56436562 | A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 |
| Q28943455 | A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3) |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q33279172 | Allelotyping of pooled DNA with 250 K SNP microarrays |
| Q35937737 | Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population |
| Q33641475 | Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus |
| Q30253080 | Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study |
| Q28744022 | Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian origin |
| Q94355861 | Association of () polymorphisms with breast cancer risk |
| Q45198128 | Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach |
| Q46402532 | Association of NCOA3 polymorphisms with breast cancer risk |
| Q54620954 | Association of prolactin and its receptor gene regions with familial breast cancer. |
| Q53143255 | Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer. |
| Q60917552 | Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q60912720 | Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q57664869 | B-RAFmutations in tumors from melanoma-breast cancer families |
| Q42478728 | Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism |
| Q40286050 | Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients |
| Q100382837 | Cancer Predisposition Genes in Cancer-Free Families |
| Q38238386 | Cancer in immigrants as a pointer to the causes of cancer |
| Q39002612 | Cancer of unknown primary is associated with diabetes |
| Q53639960 | Cancer risk in patients with type 2 diabetes mellitus and their relatives. |
| Q58778223 | Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients |
| Q28943530 | Chromosome 7p11.2 (EGFR) variation influences glioma risk |
| Q55429019 | Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer. |
| Q43609776 | Colorectal cancer risk and patients' survival: influence of polymorphisms in genes somatically mutated in colorectal tumors |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q28943395 | Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk |
| Q28943335 | Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk |
| Q44616518 | Concordance of survival in family members with prostate cancer |
| Q33889157 | Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies |
| Q51369052 | Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy. |
| Q58549362 | Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histology |
| Q58797957 | Correction: Inherited variants in genes somatically mutated in thyroid cancer |
| Q28602609 | Correspondence: SEMA4A variation and risk of colorectal cancer |
| Q57610482 | Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk? |
| Q50118895 | Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels. |
| Q36839027 | Deciphering the 8q24.21 association for glioma |
| Q34182454 | Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection |
| Q42488665 | Determination of allele frequency in pooled DNA: comparison of three PCR-based methods |
| Q34755230 | Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study |
| Q36323304 | Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma |
| Q44447517 | Effect of autoimmune diseases on risk and survival in female cancers |
| Q44445830 | Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk |
| Q91152093 | Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance |
| Q43494221 | Ethnic differences in breast cancer risk and survival: a study on immigrants in Sweden |
| Q36934955 | Etiologic impact of known cancer susceptibility genes |
| Q36001617 | Evidence of Inbreeding in Hodgkin Lymphoma |
| Q56350284 | Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family |
| Q59355532 | Familial Ovarian Cancer Clusters with Other Cancers |
| Q49958973 | Familial Risks Between Urolithiasis and Cancer. |
| Q40085390 | Familial associations of female breast cancer with other cancers |
| Q40072676 | Familial associations of male breast cancer with other cancers |
| Q47430992 | Familial risks for gallstones in the population of Sweden |
| Q55472945 | Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden. |
| Q45875774 | Familial risks in urolithiasis in the population of sweden |
| Q57815823 | Familial risks of second primary cancers and mortality in ovarian cancer patients |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q46425638 | Functional TLR5 genetic variants affect human colorectal cancer survival |
| Q38753149 | Functional germline variants in driver genes of breast cancer |
| Q48877969 | GWAS-identified common variants for obesity are not associated with the risk of developing colorectal cancer. |
| Q40043371 | Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism |
| Q39597050 | Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci |
| Q60937379 | Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology |
| Q36947272 | Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa |
| Q46071107 | Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome |
| Q31126135 | Genetic variants in hormone-related genes and risk of breast cancer |
| Q58123677 | Genetic variation associated with chromosomal aberration frequency: A genome-wide association study |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q53218077 | Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival. |
| Q51776169 | Genetic variation in adipokine genes and risk of colorectal cancer. |
| Q43573965 | Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q44752870 | Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk |
| Q45868620 | Genetics of gallbladder cancer |
| Q45087021 | Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. |
| Q54664157 | Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q34677689 | Genome-wide association study identifies multiple susceptibility loci for multiple myeloma |
| Q36511162 | Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma |
| Q59795648 | Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma |
| Q47125417 | Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility |
| Q40134213 | Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts. |
| Q28943543 | Genome-wide association study on differentiated thyroid cancer |
| Q49055343 | Genome-wide investigation of gene-environment interactions in colorectal cancer. |
| Q38856161 | Genomewide association study on monoclonal gammopathy of unknown significance (MGUS). |
| Q37225491 | Germline genetics of cancer of unknown primary (CUP) and its specific subtypes |
| Q36695195 | Heritability estimates on Hodgkin's lymphoma: a genomic- versus population-based approach |
| Q33289259 | High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk |
| Q44514613 | Human estrogen receptor beta 548 is not a common variant in three distinct populations |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q58743933 | Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma |
| Q41439347 | Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population |
| Q36272742 | Inbreeding and homozygosity in breast cancer survival |
| Q98612923 | Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues |
| Q44485933 | Incidence and familial risks in pituitary adenoma and associated tumors |
| Q31106882 | Incidence and survival in non-hereditary amyloidosis in Sweden |
| Q35020585 | Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases |
| Q42628777 | Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease |
| Q43496882 | Inherited genetic susceptibility to monoclonal gammopathy of unknown significance |
| Q33565488 | Inherited variants in genes somatically mutated in thyroid cancer |
| Q48097366 | Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer |
| Q58551405 | Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney disease. Role of GST polymorphisms |
| Q43255116 | Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients |
| Q41524088 | Metabolic gene variants associated with chromosomal aberrations in healthy humans |
| Q37558210 | Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort |
| Q58797777 | Multiple myeloma: family history and mortality in second primary cancers |
| Q43473528 | New cancer susceptibility loci: population and familial risks |
| Q35160562 | Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk |
| Q48657228 | Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. |
| Q36063925 | Origin of B-Cell Neoplasms in Autoimmune Disease |
| Q28386134 | Pedigree based DNA sequencing pipeline for germline genomes of cancer families |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q45014455 | Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers |
| Q34797294 | Polymorphisms in CTNNBL1 in relation to colorectal cancer with evolutionary implications |
| Q43613530 | Polymorphisms in genes involved in GH1 release and their association with breast cancer risk |
| Q46542867 | Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker |
| Q33505042 | Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis |
| Q53668727 | Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. |
| Q34542850 | Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis |
| Q44503540 | Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association |
| Q46870627 | Polymorphisms in the growth hormone receptor: a case-control study in breast cancer |
| Q53514882 | Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. |
| Q34251720 | Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer |
| Q54704915 | Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. |
| Q33709693 | Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study |
| Q38294581 | Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q57226861 | Preventable breast cancer is postmenopausal |
| Q34573212 | Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression |
| Q44085022 | Proper controls for SNP studies? |
| Q43928434 | Re: "underlying genetic models of inheritance in established type 2 diabetes associations". |
| Q44753987 | Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer |
| Q28606428 | Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis |
| Q36265886 | Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer |
| Q112641757 | Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma |
| Q56436732 | Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer |
| Q34514971 | Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study |
| Q46640446 | Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas |
| Q40212072 | Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis |
| Q35960205 | Runs of homozygosity and inbreeding in thyroid cancer |
| Q47121299 | SNPs related to vitamin D and breast cancer risk: a case-control study |
| Q57319595 | Searching for the missing heritability of complex diseases |
| Q90217327 | Second Primary Cancers in Melanoma Patients Critically Shorten Survival |
| Q55297932 | Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. |
| Q34433631 | Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases |
| Q24795928 | Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events |
| Q34304340 | Single nucleotide polymorphisms in breast cancer |
| Q46577430 | Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study |
| Q39743981 | Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome |
| Q57664913 | Single nucleotide polymorphisms in theXPGgene: Determination of role in DNA repair and breast cancer risk |
| Q36039522 | Subsequent Type 2 Diabetes in Patients with Autoimmune Disease |
| Q30432018 | Subsequent brain tumors in patients with autoimmune disease |
| Q38624936 | Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis |
| Q36662145 | Survival in bladder and renal cell cancers is familial |
| Q47573687 | Survival in breast cancer is familial |
| Q41078628 | Survival in familial and non-familial breast cancer by age and stage at diagnosis |
| Q46741633 | Survival in non-Hodgkin's lymphoma by histology and family history |
| Q43660089 | Survival in ovarian cancer patients by histology and family history |
| Q34772247 | Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development |
| Q33699957 | Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome |
| Q57319812 | Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families |
| Q36766450 | Thalassemia and sickle cell anemia in Swedish immigrants: Genetic diseases have become global |
| Q33344459 | The 'common disease-common variant' hypothesis and familial risks |
| Q43175213 | The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells |
| Q28391289 | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma |
| Q28272141 | The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development |
| Q37027418 | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
| Q36670492 | The balance between heritable and environmental aetiology of human disease |
| Q53365943 | The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. |
| Q53639998 | The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. |
| Q48310022 | Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study |
| Q28943378 | Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma |
| Q46493668 | Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis |
| Q90723807 | Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways |
| Q46521646 | c-MYC Asn11Ser is associated with increased risk for familial breast cancer |
Search more.